Sintx Technologies (SINT) closed at $1.56 on November 6, 2026, down 3.7% from the previous close, on volume of 39,379 shares (30-day average 68,808).
Data as of November 6, 2026.
TipRanks (Sat, 7-Nov 7:55 AM ET)
Sintx Technologies GAAP EPS of -$0.24 beats by $0.07, revenue of $2.2M beats by $0.87M
Seeking Alpha News (Thu, 5-Nov 5:52 PM ET)
SINTX Technologies Reports Strong Third-Quarter Revenue Growth and Narrower Losses
TipRanks (Thu, 5-Nov 5:12 PM ET)
SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization
Globe Newswire (Thu, 5-Nov 4:02 PM ET)
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast
Globe Newswire (Thu, 22-Oct 9:00 AM ET)
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
Globe Newswire (Thu, 1-Oct 9:00 AM ET)
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
Globe Newswire (Mon, 14-Sep 9:00 AM ET)
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Tue, 8-Sep 8:00 AM ET)
SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement
Globe Newswire (Thu, 13-Aug 9:00 AM ET)
Globe Newswire (Tue, 11-Aug 4:06 PM ET)
SINTX Technologies Inc is a biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for other medical and specialized industrial applications. SINTX has 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and its SiNERGY technology platform being developed for biocomposite and 3D printing applications.
Sintx Technologies trades on the NASDAQ stock market under the symbol SINT.
As of November 9, 2026, SINT stock price climbed to $1.58 with 31,339 million shares trading.
SINT has a beta of 2.16, meaning it tends to be more sensitive to market movements. SINT has a correlation of 0.19 to the broad based SPY ETF.
SINT has a market cap of $11.94 million. This is considered a Sub-Micro Cap stock.
Last quarter Sintx Technologies reported $2 million in Revenue and -$.24 earnings per share. This beat revenue expectation by $856,670 and exceeded earnings estimates by $.07.
In the last 3 years, SINT traded as high as $106.00 and as low as $1.40.
The top ETF exchange traded funds that SINT belongs to (by Net Assets): VXF.
SINT has underperformed the market in the last year with a return of -53.4%, while the SPY ETF gained +13.4%. In the last 3 month period, SINT fell short of the market, returning -3.1%, while SPY returned -1.8%. However, in the most recent 2 weeks SINT has outperformed the stock market by returning 0.0%, while SPY returned -0.9%.
SINT support price is $1.48 and resistance is $1.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SINT shares will trade within this expected range on the day.